Studies to elucidate the pathogenic molecular mechanism of Lcn2 in atherosclerosis and CAD have shown that the Lcn2/MMP-9 complex acts to destabilize the artery plaque [25]. The gene discussed is LCN2; the disease is atherosclerosis.